New Findings from Graduate Program of Biomedical Engineering in the Area of Cancer Research Reported [Microfluidically-generated Encapsulated Spheroids (M-gels): an All-aqueous Droplet Microfluidics Platform for Multicellular Spheroids...].

Researchers from the Graduate Program of Biomedical Engineering in Toronto, Canada, have developed a new method for creating three-dimensional clusters of cells called spheroids, which can be used as tumor models for cancer research. The method, called Microfluidically-generated Encapsulated Spheroids (M-gels), uses an all-aqueous droplet microfluidics platform to form hydrogel multicellular spheroids (MCSs) without the use of cytotoxic organic solvents. The researchers demonstrated that the MCSs remained viable for 6 days and could be used for cancer drug testing, showing dose-dependent cell death with the drug doxorubicin. This research has been peer-reviewed and published in ACS Biomaterials Science & Engineering. [Extracted from the article]